TICEBA STEM CELL EXPERTS Trademark

Trademark Overview


On Tuesday, December 22, 2020, a trademark application was filed for TICEBA STEM CELL EXPERTS with the United States Patent and Trademark Office. The USPTO has given the TICEBA STEM CELL EXPERTS trademark a serial number of 79311207. The federal status of this trademark filing is REGISTERED as of Tuesday, October 4, 2022. The TICEBA STEM CELL EXPERTS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

pharmaceutical drugs, namely pharmaceutical drugs for treatment of skin diseases, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; pharmaceutical drugs for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, the urinary system, the integumentary system, the reproductive system, for the treatment of blood diseases and disorders; pharmaceutical drugs for treatment of cancer, hormone replacement therapy preparations; pharmaceutical and veterinary preparations for treatment of vertigo, migraine, nausea, vomiting, for treatment of skin diseases, wound healing, pharmaceutical and veterinary preparations for treating diabetes, antidepressants; pharmaceutical preparations for anti-aging, pharmaceutical preparations namely antibiotics, vaccines; diagnostic agents for medical use; preparations for medical purposes, namely, for the treatment o...

Stem cells for scientific or research use; cell growth media for growing cells for scientific use

Medical services relating to the removal, treatment, processing and preservation of human blood, cord blood, human cells and tissue, stem cells and bone marrow, also in the field of regenerative medicine, including tissue engineering; medical services in connection with the removal, treatment and processing of human tissue and stem cells, human tissue and stem cell bank services, including in the field of regenerative medicine, including tissue engineering; medical services relating to the cultivation and extraction of stem cells; medical services in connection with the cultivation and extraction of stem cells

Stem cell research; scientific research and development and medical research and development in the field of stem cells, vaccines and medications; scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering, genetics and genetic engineering; scientific research for medical purposes; medical research; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information on medical and scientific research on pharmaceutical products; biomedical research; preparation of reports relating to scientific research, namely, technical writing for others; research in the field of biotechnology; research in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field ...
ticeba stem cell experts

General Information


Serial Number79311207
Word MarkTICEBA STEM CELL EXPERTS
Filing DateTuesday, December 22, 2020
Status700 - REGISTERED
Status DateTuesday, October 4, 2022
Registration Number6861489
Registration DateTuesday, October 4, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements


Goods and Servicespharmaceutical drugs, namely pharmaceutical drugs for treatment of skin diseases, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; pharmaceutical drugs for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, the urinary system, the integumentary system, the reproductive system, for the treatment of blood diseases and disorders; pharmaceutical drugs for treatment of cancer, hormone replacement therapy preparations; pharmaceutical and veterinary preparations for treatment of vertigo, migraine, nausea, vomiting, for treatment of skin diseases, wound healing, pharmaceutical and veterinary preparations for treating diabetes, antidepressants; pharmaceutical preparations for anti-aging, pharmaceutical preparations namely antibiotics, vaccines; diagnostic agents for medical use; preparations for medical purposes, namely, for the treatment of skin diseases, allergy medication, herbal extracts for medical use, reagents for medical use; substances for medical use, namely, for regeneration of tissue and anti-inflammation; stem cells for medical purposes; stem cells for veterinary purposes; stem cells for aesthetic purposes, namely, for anti-aging, for use in dermatology procedures; somatic stem cell therapeutics, namely, for medical therapeutic use; fibroblasts for medical use; fibroblasts for aesthetic purposes, namely, for use in dermatology procedures; pharmaceutical implants, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical for treatment of skin diseases, blood diseases, vertigo, nausea, vomiting, migraine, respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the musculoskeletal system, the urinary system, the integumentary system, and the reproductive system; surgical implants derived from stem cells, namely, surgical implants derived from living tissues and living stem cells; surgical implants derived from fibroblasts, namely, surgical implants comprised of living fibroblasts tissue cells; biological tissue for implantation, namely, implants comprising living tissues; cell growth media for growing cells for medical use; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissue, namely, surgical implants comprised of living tissues; biotechnologically engineered tissue products, namely, living tissue cell sheets and plasters for wound healing and burns, biological eye lens grafts, bone grafts in the nature of biological bone tissue for grafting, biological tissue grafts, human allograft tissue
Goods and ServicesStem cells for scientific or research use; cell growth media for growing cells for scientific use
Goods and ServicesMedical services relating to the removal, treatment, processing and preservation of human blood, cord blood, human cells and tissue, stem cells and bone marrow, also in the field of regenerative medicine, including tissue engineering; medical services in connection with the removal, treatment and processing of human tissue and stem cells, human tissue and stem cell bank services, including in the field of regenerative medicine, including tissue engineering; medical services relating to the cultivation and extraction of stem cells; medical services in connection with the cultivation and extraction of stem cells
Disclaimer with Predetermined Text"STEM CELL EXPERTS"
Goods and ServicesStem cell research; scientific research and development and medical research and development in the field of stem cells, vaccines and medications; scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering, genetics and genetic engineering; scientific research for medical purposes; medical research; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information on medical and scientific research on pharmaceutical products; biomedical research; preparation of reports relating to scientific research, namely, technical writing for others; research in the field of biotechnology; research in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development services for the pharmaceutical industry; research and development services in the field of biotechnology; development of industrial processes, namely, engineering of industrial processes in the field of for packaging, storage and transport of human tissue and human adult ancestral cells, engineering of industrial processes to manufacture stem cells; industrial process research in the field of regenerative medicine and tissue engineering, chemical engineering

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, May 21, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 21, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 21, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressDE

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressDE

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressDE

Trademark Events


Event DateEvent Description
Monday, February 20, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 26, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 26, 2023FINAL DISPOSITION PROCESSED
Wednesday, January 4, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 4, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 4, 2022REGISTERED-PRINCIPAL REGISTER
Monday, July 25, 2022NOTIFICATION PROCESSED BY IB
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 29, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 9, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 8, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, December 22, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, December 22, 2021FINAL REFUSAL E-MAILED
Wednesday, December 22, 2021FINAL REFUSAL WRITTEN
Tuesday, December 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 19, 2021REFUSAL PROCESSED BY IB
Monday, June 28, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 28, 2021REFUSAL PROCESSED BY MPU
Friday, June 18, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, June 17, 2021NON-FINAL ACTION WRITTEN
Wednesday, June 16, 2021ASSIGNED TO EXAMINER
Tuesday, May 25, 2021APPLICATION FILING RECEIPT MAILED
Friday, May 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 20, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB